Literature DB >> 26077795

Pharmacist intervention for blood pressure control: medication intensification and adherence.

Tyler H Gums1, Liz Uribe2, Mark W Vander Weg3, Paul James4, Christopher Coffey2, Barry L Carter5.   

Abstract

The objective of this study was to describe medication adherence and medication intensification in a physician-pharmacist collaborative management (PPCM) model compared with usual care. This study was a prospective, cluster, randomized study in 32 primary care offices from 15 states. The primary outcomes were medication adherence and anti-hypertensive medication changes during the first 9 months of the intervention. The 9-month visit was completed by 539 patients, 345 of which received the intervention. There was no significant difference between intervention and usual care patients in regards to medication adherence at 9 months. Intervention patients received significantly more medication changes (4.9 vs.1.1; P = .0003) and had significantly increased use of diuretics and aldosterone antagonists when compared with usual care (P = .01).The PPCM model increased medication intensification; however, no significant change in medication adherence was detected. PPCM models will need to develop non-adherence identification and intervention methods to further improve the potency of the care team.
Copyright © 2015 American Society of Hypertension. All rights reserved.

Entities:  

Keywords:  Collaboration; hypertension; team-based care

Mesh:

Substances:

Year:  2015        PMID: 26077795      PMCID: PMC4508208          DOI: 10.1016/j.jash.2015.05.005

Source DB:  PubMed          Journal:  J Am Soc Hypertens        ISSN: 1878-7436


  36 in total

1.  Characteristics of patients with uncontrolled hypertension in the United States.

Authors:  D J Hyman; V N Pavlik
Journal:  N Engl J Med       Date:  2001-08-16       Impact factor: 91.245

2.  Recommendations for blood pressure measurement in humans and experimental animals: Part 1: blood pressure measurement in humans: a statement for professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research.

Authors:  Thomas G Pickering; John E Hall; Lawrence J Appel; Bonita E Falkner; John Graves; Martha N Hill; Daniel W Jones; Theodore Kurtz; Sheldon G Sheps; Edward J Roccella
Journal:  Hypertension       Date:  2004-12-20       Impact factor: 10.190

3.  Inadequate management of blood pressure in a hypertensive population.

Authors:  D R Berlowitz; A S Ash; E C Hickey; R H Friedman; M Glickman; B Kader; M A Moskowitz
Journal:  N Engl J Med       Date:  1998-12-31       Impact factor: 91.245

4.  The Collaborative Cardiovascular Risk Reduction in Primary Care (CCARP) study.

Authors:  Charity D Evans; Dean T Eurich; Jeff G Taylor; David F Blackburn
Journal:  Pharmacotherapy       Date:  2010-08       Impact factor: 4.705

5.  Description of pharmacist interventions during physician-pharmacist co-management of hypertension.

Authors:  Shannon J Von Muenster; Barry L Carter; Cynthia A Weber; Michael E Ernst; Jessica L Milchak; Jennifer J G Steffensmeier; Yinghui Xu
Journal:  Pharm World Sci       Date:  2007-08-21

6.  Race/Ethnicity, disability, and medication adherence among medicare beneficiaries with heart failure.

Authors:  Yuting Zhang; Seo Hyon Baik
Journal:  J Gen Intern Med       Date:  2013-12-24       Impact factor: 5.128

7.  When more is not better: treatment intensification among hypertensive patients with poor medication adherence.

Authors:  Michele Heisler; Mary M Hogan; Timothy P Hofer; Julie A Schmittdiel; Manel Pladevall; Eve A Kerr
Journal:  Circulation       Date:  2008-05-27       Impact factor: 29.690

8.  Hypertensive patients' race, health beliefs, process of care, and medication adherence.

Authors:  Nancy R Kressin; Fei Wang; Judith Long; Barbara G Bokhour; Michelle B Orner; James Rothendler; Christine Clark; Surekha Reddy; Waldemar Kozak; Laura P Kroupa; Dan R Berlowitz
Journal:  J Gen Intern Med       Date:  2007-03-16       Impact factor: 5.128

9.  Thirty-year Survival for Black and White Hypertensive Individuals in the Evans County Heart Study and the Hypertension Detection and Follow-up Program.

Authors:  Daniel T Lackland; Brent M Egan; William K Mountford; Andrea D Boan; Denis A Evans; Gregory Gilbert; Daniel L McGee
Journal:  J Am Soc Hypertens       Date:  2008 Nov-Dec

10.  A cluster randomized trial to evaluate physician/pharmacist collaboration to improve blood pressure control.

Authors:  Barry L Carter; George R Bergus; Jeffrey D Dawson; Karen B Farris; William R Doucette; Elizabeth A Chrischilles; Arthur J Hartz
Journal:  J Clin Hypertens (Greenwich)       Date:  2008-04       Impact factor: 3.738

View more
  13 in total

1.  Cluster-Randomized Trial to Evaluate a Centralized Clinical Pharmacy Service in Private Family Medicine Offices.

Authors:  Barry L Carter; Barcey Levy; Brian Gryzlak; Yinghui Xu; Elizabeth Chrischilles; Jeffrey Dawson; Mark Vander Weg; Alan Christensen; Paul James; Linnea Polgreen
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2018-06

2.  Evaluation of Pharmacists' Work in a Physician-Pharmacist Collaborative Model for the Management of Hypertension.

Authors:  Brian J Isetts; Daniel E Buffington; Barry L Carter; Marie Smith; Linnea A Polgreen; Paul A James
Journal:  Pharmacotherapy       Date:  2016-03-18       Impact factor: 4.705

3.  Physician-pharmacist collaboration versus usual care for treatment-resistant hypertension.

Authors:  Steven M Smith; Nicholas W Carris; Eric Dietrich; John G Gums; Liz Uribe; Christopher S Coffey; Tyler H Gums; Barry L Carter
Journal:  J Am Soc Hypertens       Date:  2016-01-18

4.  Incorporating Patients' Social Determinants of Health into Hypertension and Depression Care: A Pilot Randomized Controlled Trial.

Authors:  Heather F McClintock; Hillary R Bogner
Journal:  Community Ment Health J       Date:  2017-04-04

5.  Pharmacist Intervention for Blood Pressure Control in Patients with Diabetes and/or Chronic Kidney Disease.

Authors:  Maxwell D Anderegg; Tyler H Gums; Liz Uribe; Eric J MacLaughlin; James Hoehns; Oralia V Bazaldua; Timothy J Ives; David L Hahn; Christopher S Coffey; Barry L Carter
Journal:  Pharmacotherapy       Date:  2018-02-23       Impact factor: 4.705

6.  Cost-Effectiveness of a Physician-Pharmacist Collaboration Intervention to Improve Blood Pressure Control.

Authors:  Linnea A Polgreen; Jayoung Han; Barry L Carter; Gail P Ardery; Christopher S Coffey; Elizabeth A Chrischilles; Paul A James
Journal:  Hypertension       Date:  2015-11-02       Impact factor: 10.190

7.  Architecting Process of Care: A randomized controlled study evaluating the impact of providing nonadherence information and pharmacist assistance to physicians.

Authors:  Margaret McConnell; William Rogers; Emilia Simeonova; Ira B Wilson
Journal:  Health Serv Res       Date:  2019-12-13       Impact factor: 3.402

Review 8.  Team-Based Care with Pharmacists to Improve Blood Pressure: a Review of Recent Literature.

Authors:  Korey A Kennelty; Linnea A Polgreen; Barry L Carter
Journal:  Curr Hypertens Rep       Date:  2018-01-18       Impact factor: 5.369

9.  Collaborative care model for hypertension.

Authors:  Barry L Carter
Journal:  J Clin Hypertens (Greenwich)       Date:  2017-12-13       Impact factor: 3.738

10.  Interventions for improving medication-taking ability and adherence in older adults prescribed multiple medications.

Authors:  Amanda J Cross; Rohan A Elliott; Kate Petrie; Lisha Kuruvilla; Johnson George
Journal:  Cochrane Database Syst Rev       Date:  2020-05-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.